# Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium

> **NCT01109056** · PHASE2 · COMPLETED · sponsor: **Allergan** · enrollment: 115 (actual)

## Conditions studied

- Pterygium

## Interventions

- **DRUG:** cyclosporine ophthalmic emulsion 0.05%
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT01109056
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-05
- **Final completion:** 2011-06
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2012-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01109056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01109056, "Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01109056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*